Product Information
ABACAVIR-LAMIVUDINE 600-300 MG is a generic product labeled by Aurobindo Pharma Limited, priced at $1.4542 per EA under NDC 65862033530. Its NADAC has been published 330 times since Mar 4, 2020.
Strength
600; 300 mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862033530
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ABACAVIR SULFATE; LAMIVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA090159On Market Since
11/15/2018
Pharmacological Classes
Price Statistics
The NADAC for ABACAVIR-LAMIVUDINE 600-300 MG has been published 330 times since Mar 4, 2020, and over the history we have for it it has declined 51.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4542 per EA |
|---|---|
| All-time high | $3.0410 (Nov 11, 2020) |
| All-time low | $1.2091 (Nov 22, 2023) |
| 52-week high | $1.6992 |
| 52-week low | $1.2621 |
| Median price | $1.8679 |
| Average price | $1.9201 |
| Largest weekly change | +64.5% (Nov 23, 2022) |
| Weeks tracked | 330 |
| Tracking since | Mar 4, 2020 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ABACAVIR-LAMIVUDINE 600-300 MG?
The current National Average Drug Acquisition Cost (NADAC) for ABACAVIR-LAMIVUDINE 600-300 MG, manufactured by Aurobindo Pharma Limited, is $1.4542 per EA (NDC 65862033530), effective Jun 24, 2026.
How has the price of ABACAVIR-LAMIVUDINE 600-300 MG changed over time?
Over the history we have for it, the NADAC for ABACAVIR-LAMIVUDINE 600-300 MG has declined 51.6%. It has been tracked across 330 weekly CMS publications since Mar 4, 2020.
What are the highest and lowest recorded NADAC prices for ABACAVIR-LAMIVUDINE 600-300 MG?
Since Mar 4, 2020, the NADAC for ABACAVIR-LAMIVUDINE 600-300 MG has ranged from a low of $1.2091 (Nov 22, 2023) to a high of $3.0410 (Nov 11, 2020), with a median of $1.8679 per EA.
Are there cheaper alternatives to ABACAVIR-LAMIVUDINE 600-300 MG?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ABACAVIR-LAMIVUDINE 600-300 MG, but none are currently priced below it.
Who manufactures ABACAVIR-LAMIVUDINE 600-300 MG?
ABACAVIR-LAMIVUDINE 600-300 MG (NDC 65862033530) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification